Human endogenous retroviruses are poorly annotated intervals of the human genome that have immunomodulatory effects and may be selectively transcribed in cancers.
Here, we test whether previously unannotated retroviral elements are selectively transcribed in colorectal cancer.
We identify seven proviruses that could serve as novel biomarkers or targets of immunotherapy.
